Corporate Update

GeoVax to Announce Q2 2025 Financial Results and Corporate Update

GeoVax to Announce Q2 2025 Financial Results and Corporate Update

GeoVax Labs, Inc. is set to disclose its second quarter 2025 financial outcomes and a corporate update, highlighting its progress in vaccine and immunotherapy development for infectious diseases and cancer.

July 24, 2025
GeoVax Set to Disclose Q1 2025 Financial Results and Provide Corporate Update

GeoVax Set to Disclose Q1 2025 Financial Results and Provide Corporate Update

Clinical-stage biotechnology company GeoVax Labs will release its first quarter 2025 financial results and host a conference call, offering insights into its COVID-19 vaccine development and oncology programs. The announcement provides stakeholders an opportunity to learn about the company's recent progress and strategic direction.

April 23, 2025